Cite

HARVARD Citation

    Takegawa, N. et al. (2019). [fam‐] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification. International journal of cancer. 145 (12), pp. 3414-3424. [Online]. 
  
Back to record